Poolbeg Pharma PLC (POLB)

Poolbeg Pharma PLC has recorded no insider trading activity within the past three months. The most recent transactions occurred in February 2024, when the Chief Executive Officer and Executive Chairman executed share purchases. Prior to these events, the last recorded acquisition by leadership took place during May 2022.
Ticker: POLB Exchange: LSE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Poolbeg Pharma PLC. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Jeremy Skillington Chief Executive Officer Officer
Transaction date
Purchase
Price
416.67
Quantity 86,052
Value £1,190,332
Cathal Friel Executive Chairman Director
Transaction date
Purchase
Price
420.51
Quantity 50,460
Value £1,821,167
Jeremy Skillington Chief Executive Officer Officer
Transaction date
Purchase
Price
412.77
Quantity 52,084
Value £4,473,811
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-22 2024-02-21 B Purchase Jeremy Skillington

Chief Executive Officer

Officer
86,052
416.67
£1,190,332
86,052 416.67 £1,190,332
2024-02-19 2024-02-19 B Purchase Cathal Friel

Executive Chairman

Director
50,460
420.51
£1,821,167
50,460 420.51 £1,821,167
2022-10-06 2022-05-10 B Purchase Jeremy Skillington

Chief Executive Officer

Officer
52,084
412.77
£4,473,811
52,084 412.77 £4,473,811